Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | FTRE | BCAX | ||
| Company | Recursion Pharmaceuticals Inc Cl A | Fortrea Holdings Inc | Bicara Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.28 | 17.93 | 26.09 | ||
| High | 3.50 | 18.49 | 26.95 | ||
| Low | 3.19 | 17.87 | 25.04 | ||
| Last | 3.50 | 18.14 | 25.86 | ||
| Change | +0.41 | +0.54 | +0.94 | ||
| Percent Change | +13.27% | +3.07% | +3.77% | ||
| Volume | 30,369,699 | 1,034,000 | 670,400 | ||
| 20-Day Average Volume | 15,850,950 | 1,734,335 | 670,960 | ||
| Previous | 3.09 | 17.60 | 24.92 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.16 | 18.78 | 26.09 | ||
| 20-Day Raw Stochastic | 100.00% | 28.57% | 50.00% | ||
| 20-Day Relative Strength | 56.60 | 51.18 | 50.00 | ||
| Weighted Alpha | -25.99 | +129.87 | +77.32 | ||
| Today's Opinion | 32% Sell | 88% Buy | 40% Buy | ||
| Yesterday's Opinion | 100% Sell | 72% Buy | 56% Buy | ||
| Last Month's Opinion | 72% Sell | 88% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.38% since 08/12/26 | -1.04% since 08/12/26 | +4.99% since 08/12/26 | ||
| Low | 2.92 on 08/18/26 | 16.84 on 08/14/26 | 23.27 on 08/14/26 | ||
| High | 3.50 on 08/19/26 | 18.68 on 08/13/26 | 26.95 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +18.85% since 07/17/26 | +2.14% since 07/17/26 | -6.84% since 07/17/26 | ||
| Low | 2.84 on 07/20/26 | 16.84 on 08/14/26 | 22.80 on 08/11/26 | ||
| High | 3.50 on 08/19/26 | 21.39 on 07/29/26 | 28.92 on 07/27/26 | ||
| 3-Month | |||||
| %Chg | +22.81% since 05/19/26 | +32.31% since 05/19/26 | +29.11% since 05/19/26 | ||
| Low | 2.81 on 05/20/26 | 13.00 on 05/26/26 | 19.09 on 06/03/26 | ||
| High | 4.09 on 07/06/26 | 21.39 on 07/29/26 | 30.99 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | -5.91% since 02/19/26 | +64.76% since 02/19/26 | +67.70% since 02/19/26 | ||
| Low | 2.77 on 05/19/26 | 8.55 on 04/06/26 | 15.13 on 02/23/26 | ||
| High | 4.09 on 07/06/26 | 21.39 on 07/29/26 | 30.99 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,654,207 | 1,673,760 | 1,649,031 | ||
| Shares Outstanding, K | 535,342 | 95,100 | 66,173 | ||
| Annual Sales, $M | 74,680,000 | 2,723,400,000 | 0 | ||
| Annual Net Income, $M | -644,760,000 | -986,200,000 | -137,950,000 | ||
| Last Qtr Sales, $M | 7,670,000 | 678,200,000 | 0 | ||
| Last Qtr Income, $M | -131,010,000 | -13,200,000 | -55,440,000 | ||
| 60-Month Beta | 1.03 | 1.99 | -0.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 08/05/26 | 0.23 on 07/29/26 | -0.82 on 08/11/26 | ||
| Latest Earnings Date | 11/04/26 | 11/04/26 | 11/09/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 30.17 | 0.00 | ||